Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. MagForce AG
  6. Summary
    MF6   DE000A0HGQF5

MAGFORCE AG

(MF6)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
11/24/2021 11/25/2021 11/26/2021 11/29/2021 11/30/2021 Date
3.38(c) 3.3(c) 3.34(c) 3.27(c) 3.14 Last
13 919 7 586 10 831 27 689 37 300 Volume
+3.68% -2.37% +1.21% -2.10% -3.98% Change
More quotes
Estimated financial data (e)
Sales 2021 3,02 M 3,43 M 3,43 M
Net income 2021 -6,35 M -7,21 M -7,21 M
Net Debt 2021 26,6 M 30,2 M 30,2 M
P/E ratio 2021 -21,3x
Yield 2021 -
Sales 2022 12,9 M 14,7 M 14,7 M
Net income 2022 -1,93 M -2,19 M -2,19 M
Net Debt 2022 25,8 M 29,4 M 29,4 M
P/E ratio 2022 -35,0x
Yield 2022 -
Capitalization 96,3 M 109 M 109 M
EV / Sales 2021 40,7x
EV / Sales 2022 9,44x
Nbr of Employees 34
Free-Float 73,9%
More Financials
Company
Magforce AG is a Germany-based company engaged in the provision of nanotechnology solutions for health sector. Its non-invasive technology uses magnetic nanoparticles to combat tumors, without harmful effect on the healthy tissues. The Company's range of treatment products includes NanoTherm Therapie for treating tumors locally; NanoTherm, a fluid containing ferrous oxide molecules that penetrate deeply into the... 
More about the company
Ratings of MagForce AG
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about MAGFORCE AG
11/05MAGFORCE AG : MagForce USA, Inc. has Received FDA's Approval to Proceed with Stage 2B with..
EQ
11/05MagForce AG and Magforce USA, Inc. Receives FDA's Approval to Proceed with Stage 2B wit..
CI
10/28MagForce AG Reports Earnings Results for the Half Year Ended June 30, 2021
CI
10/28MagForce AG Publishes Financial Results for H1/2021 and Operative Highlights
EQ
10/28MagForce AG Provides Revenue Guidance for the Year 2021
CI
10/13MAGFORCE : Stock Jumps 11% Amid US FDA's Conditions for Approval of Prostate Cancer Study
MT
10/13MAGFORCE AG : MagForce USA, Inc. has Received FDA's Conditions for Approval of the Final P..
EQ
10/13MagForce USA, Inc. has Received FDA's Conditions for Approval of the Final Protocol of ..
CI
09/30MAGFORCE AG AND CHIP HOSPITAL MÁLAGA :
EQ
08/12MAGFORCE : announces results of 2021 Annual General Meeting and changes to the Supervisory..
EQ
06/30MAGFORCE : Publishes Financial Results for the Year 2020 and Operative Highlights
EQ
06/30Magforce Ag Announces Earnings Results for the Year Ended December 31, 2020
CI
06/29ANALYST RECOMMENDATIONS : Admiral, Barclays, Burberry, Rio Tinto, Tesla...
06/07MAGFORCE : Supports World Brain Tumor Day and Informs about Various Patient Events to Rais..
EQ
04/26MAGFORCE : Releases Additional Positive Data From Study Of NanoTherm Therapy System
MT
More news
News in other languages on MAGFORCE AG
11/15MAGFORCE AG (VON GBC AG) : Kaufen
11/15MAGFORCE AG (VON GBC AG) : Buy
11/05MAGFORCE AG : MagForce USA erhält FDA-Genehmigung die Stufe 2b der pivotalen US-Studie zur..
10/28MagForce AG gibt Finanzergebnisse für das erste Halbjahr 2021 und operative Highlights ..
10/28MagForce AG fournit des prévisions de revenus pour l'année 2021
More news
Analyst Recommendations on MAGFORCE AG
More recommendations
Chart MAGFORCE AG
Duration : Period :
MagForce AG Technical Analysis Chart | MF6 | DE000A0HGQF5 | MarketScreener
Technical analysis trends MAGFORCE AG
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 3,27 €
Average target price 11,28 €
Spread / Average Target 245%
EPS Revisions
Managers and Directors
Benjamin J. Lipps Chairman-Management Board & CEO
Christian von Volkmann Chief Financial Officer
Andreas Jordan Chief Scientific Officer
Klemens Hallmann Deputy Chairman-Supervisory Board
Stefan Schütze Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
MAGFORCE AG-34.34%109
MODERNA, INC.252.74%149 412
LONZA GROUP AG28.41%58 671
IQVIA HOLDINGS INC.48.85%50 948
SEAGEN INC.-5.61%30 228
CELLTRION, INC.-40.81%24 321